Lung Cancer Considered

This edition of Lung Cancer Considered discusses important science presented at the recently completed European Lung Cancer Congress, the multidisciplinary lung cancer meeting co-organized by ESMO and IASLC. Dr. Enriqueta Felip and Dr. Fabrice Barlesi share their interpretation of the following clinical trials presented at ELCC:

Adagrasib (MRTX849) -- phase Ib expansion and phase II monotherapy cohorts

CheckMate 9LA -- randomized 719 patients with EGFR/ALK wild type NSCLC to standard chemotherapy or 2 cycles of chemotherapy with nivolumab and Ipilimumab

KEYNOTE-407-- randomized squamous NSCLC to carboplatin with choice of nab/ paclitaxel or paclitaxel, and either pembrolizumab or placebo

AMG 757-- BiTE: bispecific T-cell engager targeting DLL3 and engaging CD3

CAMEL-sq trial-- phase III randomized trial in patients with advanced squamous NSCLC

The latest edition of Lung Cancer Considered features a discussion on a virtual tumor board case involving squamous cell lung cancer. Our guests are Dr. Enriqueta Felip, who is a professor of medicine and section in chief, Medical Oncology and Department Director of Thoracic Oncology at the Vall d’Hebron University Hospital in Barcelona. Joining Dr. Felip is Dr. Paul Paik, an associate attending physician and clinical director, of the Thoracic Oncology Service Department of Medicine Memorial Sloan Kettering Cancer Center in New York.

This special episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and co-host Paul Bunn. Dr. Liu and Dr. Bunn are joined by, Dr. Tal Zaks, the chief medical officer at Moderna, and Dr. Amy Moore, a trained virologist and cancer researcher. Dr. Bunn is the founding director of the University of Colorado Cancer Center, former president of IASLC and ASCO. Dr. Moore serves as the director of Science and Research for the GO2 Foundation for Lung Cancer. Together, they discuss the development of the Moderna COVID-19 vaccine what lung cancer patients, doctors and advocates should know.

The latest episode of Lung Cancer Considered features a conversation between host, Dr. Stephen Liu and Dr. Myung-Ju Ahn, professor in the Department of Hematology-Oncology at the Samsung Medical Center, Sungkyunkwan University School of Medicine in South Korea. Together they discuss Dr. Ahn's career and her work in ROS1 lung cancer.

The latest episode of Lung Cancer Considered features a conversation between host Dr. Stephen Liu and Dr. Alex Drilon, chief, early drug development at Memorial Sloan Kettering Cancer Center. Together they discuss Dr. Drilon's career and his work on RET fusions in lung cancer.

The latest episode of Lung Cancer Considered features a conversation between host Dr. Narjust Duma and Dr. Balazs Halmos, professor of oncology and chief, thoracic/head and neck oncology at Montefiore Medical Center/Albert Einstein College of Medicine in New York. Together they discuss Dr. Halmos' career and his work on EGFR mutant non-small cell lung cancer.

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma are joined by Dr. Ross Soo, a senior consultant in the Department of Hematology-Oncology at the National University of Cancer Institute Singapore to discuss highlights from the IASLC 2020 WCLC Singapore meeting. Dr. Soo, along with Dr. Yi-Long Wu and Dr. Daniel Tan, served as co-chair of the meeting. Together Dr. Liu, Dr. Duma and Dr. Soo discuss key science, highlights, benefits and challenges of the virtual meeting.

Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Duma share highlights, tips and tricks for navigating IASLC's World Conference on Lung Cancer Singapore this year. Listen to this podcast as you prepare for the world’s leading lung cancer event (held virtually January 28 – 31). Register for IASLC's WCLC at //wclc2020.iaslc.org/registration.

The latest episode of Lung Cancer Considered discusses women in thoracic oncology and the upcoming IASLC Women in Thoracic Oncology Event. Register now for this event. This episode features a conversation between host, Dr. Narjust Duma, and Dr. Heather Wakelee and Dr. Clarissa Mathias. Dr. Wakelee is a thoracic medical oncologist, Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology at Stanford University Medical Center. She is also the president-elect of the IASLC. Dr. Clarissa Mathias, Medical Oncologist at Grupo Oncoclinicas, is president of the Brazilian Society of Medical Oncology, Chair of the ASCO International Committee and a member of the IASLC Board of Directors. Together they discuss their career paths and what they are looking forward to at the Virtual Women in Thoracic Oncology Event hosted by IASLC on January 20th.

The latest episode of Lung Cancer Considered introduces its new hosts, Dr. Stephen Liu and Dr. Narjust Duma. Dr. Liu is an associate professor at the Lombardi Cancer Center at Georgetown University School of Medicine. Dr. Duma is an assistant professor of medicine and a thoracic oncologist at the University of Wisconsin. Get to know both Dr. Liu and Dr. Duma a little more and hear what their goals are in 2021 for Lung Cancer Considered.